Product Information
CLARINEX-D 12 HR 2.5-120 MG TB is a brand product labeled by Organon LLC, priced at $6.0683 per EA under NDC 78206012001. Its NADAC has been published 264 times since Sep 15, 2021.
FDA first approved this application on Feb 1, 2006.
Strength
2.5; 120 mg/1; mg/1
Manufacturer
Organon LLCNDC
78206012001
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESLORATADINE; PSEUDOEPHEDRINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA021313FDA Approved
2/1/2006
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for CLARINEX-D 12 HR 2.5-120 MG TB has been published 264 times since Sep 15, 2021, and over the history we have for it it has risen 25.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0683 per EA |
|---|---|
| All-time high | $6.0728 (Sep 16, 2026) |
| All-time low | $4.8287 (Nov 17, 2021) |
| 52-week high | $6.0728 |
| 52-week low | $5.7697 |
| Median price | $5.5518 |
| Average price | $5.5143 |
| Largest weekly change | +6.0% (Jan 18, 2023) |
| Weeks tracked | 264 |
| Tracking since | Sep 15, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the desloratadine and pseudoephedrine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
desloratadine and pseudoephedrine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLARINEX-D 12 HR 2.5-120 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CLARINEX-D 12 HR 2.5-120 MG TB, manufactured by Organon LLC, is $6.0683 per EA (NDC 78206012001), effective Sep 30, 2026.
How has the price of CLARINEX-D 12 HR 2.5-120 MG TB changed over time?
Over the history we have for it, the NADAC for CLARINEX-D 12 HR 2.5-120 MG TB has risen 25.4%. It has been tracked across 264 weekly CMS publications since Sep 15, 2021.
What are the highest and lowest recorded NADAC prices for CLARINEX-D 12 HR 2.5-120 MG TB?
Since Sep 15, 2021, the NADAC for CLARINEX-D 12 HR 2.5-120 MG TB has ranged from a low of $4.8287 (Nov 17, 2021) to a high of $6.0728 (Sep 16, 2026), with a median of $5.5518 per EA.
Are there cheaper alternatives to CLARINEX-D 12 HR 2.5-120 MG TB?
No other NADAC-published product currently shares the active ingredient and strength of CLARINEX-D 12 HR 2.5-120 MG TB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLARINEX-D 12 HR 2.5-120 MG TB?
CLARINEX-D 12 HR 2.5-120 MG TB (NDC 78206012001) is labeled by Organon LLC, and CMS classifies it as a brand product.